Cancer Clinical Trials in Portland, Oregon

5 studies are recruiting for cancer in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Connect for Cancer Prevention Study (Connect)

   Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of pe…

   Stage

   Not phased

   Ages

   30 to 70

   Site

   Kaiser Permanente Northwest, Portland, Oregon

   Locations

   10 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT04609072 on ClinicalTrials.gov

2. IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

   The purpose of this research is to assess how patients with cancer being treated with Immune Checkpoint Inhibitors (ICI) manage symptoms related to cancer and/or its treatment. Patients use a variety of ways to manage symptoms including traditional and alternative treatments including cannabis, acu…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Oregon Health and Science University, Portland, Oregon

   Locations

   2 in total

   Run by

   State University of New York at Buffalo

   See if you can join NCT06206941 on ClinicalTrials.gov

3. FOG-001 in Locally Advanced or Metastatic Solid Tumors

   The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Oregon Health and Science University, Portland, Oregon

   Locations

   33 in total

   Run by

   Parabilis Medicines, Inc.

   See if you can join NCT05919264 on ClinicalTrials.gov

4. Galleri® in the Medicare Population.

   This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.

   Stage

   Not phased

   Ages

   50 and older

   Site

   OHSU CEDAR Clinical Trials Portland, Portland, Oregon

   Locations

   61 in total

   Run by

   GRAIL, Inc.

   See if you can join NCT05673018 on ClinicalTrials.gov

5. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

   International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

   Stage

   Not phased

   Ages

   Any age

   Site

   Massive Bio SYNERGY-AI site, Portland, Oregon

   Locations

   68 in total

   Run by

   Massive Bio, Inc.

   See if you can join NCT03452774 on ClinicalTrials.gov